sales@businessmarketinsights.com   UK: +442030260021  , US: +16467917070  , Toll Free: 1800 121 6455
Pharmaceuticals North America Addictions Therapeutics Market...

North America Addictions Therapeutics Market Forecast to 2027 - COVID-19 Impact and Regional Analysis by Treatment Type (Nicotine Addiction Treatment, Alcohol Addiction Treatment, Opioid Addiction Treatment, Other Substance Addiction Treatment); Drug Type (Varenicline, Bupropion, Nicotine Replacement Products, Buprenorphine, Naltrexone, Disulfiram, Others); Treatment Center (Outpatient Treatment Center, Residential Treatment Center, Inpatient Treatment Center); Distribution Channel (Hospitals, Medical Stores, Others) and Country

TIPRE00017280 | Pages: 94 | Pharmaceuticals | Dec 2020 | Type: Regional | Status: Published

Market Introduction

Addiction is a psychological and physical inability to stop consuming drugs, alcohol, opioids, and related category substances, even though those substances have various mental and physical harms. An addiction develops dependency in a person to take that substance. So, to stop addictions, there are several options available such as drug therapy, rehabilitation, which can stop addiction in a better way.

 


Get more information on this report :



Market Overview and Dynamics

The North America Addictions Therapeutics market is expected to reach US$ 6,102.31 million by 2027 from US$ 3,715.23 million in 2019. The market is estimated to grow with a CAGR of 6.5% from 2020 to 2027. The growth of the market is attributed to rising approval of new drugs and launch of digital therapeutics to treat addiction, conduction of various awareness campaigns and government efforts to counteract drug abuse and promote medication. However, high cost associated with drug development is hindering the growth of the addiction therapeutics market.

 

Key Market Segments

Based on treatment type, the North America addictions therapeutics market is segmented into nicotine addiction treatment, alcohol addiction treatment, opioid addiction treatment, and other substance addiction treatment. The nicotine addiction treatment segment held the largest share of the market in 2019 and is estimated to register the highest CAGR in the market during the forecast period.

The North America addictions therapeutics market, based on drug type, is segmented into varenicline, bupropion, nicotine replacement products, buprenorphine, naltrexone, disulfiram, and others. The varenicline segment held the largest market share in 2019. However, the nicotine replacement products segment is anticipated to register the highest CAGR in the market during the forecast period.

By treatment center, the North America addictions therapeutics market is segmented into outpatient treatment center, residential treatment center, and inpatient treatment center. In 2019, the outpatient treatment center segment held the largest share of the market and is estimated to register the highest CAGR in the market during the forecast period.

The North America addictions therapeutics market, based on distribution channel, is segmented into hospital pharmacies, medical stores, and others. The hospital pharmacies segment held the largest share of the market in 2019. However, the medical stores segment is estimated to register the highest CAGR in the market during the forecast period.

 

Major Sources and Companies Listed

Some of the primary and secondary sources associated with this report on the North America addictions therapeutics market are the US Food and Drug Administration (FDA); Centers For Disease Control And Prevention (CDC); and American Addictions Center (AAC).

 

Reasons to buy the report

  • Determine prospective investment areas based on a detailed trend analysis of the North America addictions therapeutics market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the North America addictions therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America addictions therapeutics market.

 

 

NORTH AMERICA ADDICTIONS THERAPEUTICS MARKET SEGMENTATION

 By Treatment Type

  • Opioid Addiction Treatment
  • Alcohol Addiction Treatment
  • Nicotine Addiction Treatment
  • Other Substance Addiction Treatment

 

By Drug Type

  • Buprenorphine
  • Naltrexone
  • Bupropion
  • Disulfiram
  • Nicotine Replacement Products
  • Varenicline
  • Others

By Treatment Center

  • Inpatient Treatment Center
  • Residential Treatment Center
  • Outpatient Treatment Center

 

By Distribution Channel

  • Hospital Pharmacies
  • Medical stores
  • Others

 

By Country

  • United States
  • Canada
  • Mexico

 

Company Profiles

  • Indivior PLC
  • Pfizer Inc
  • GlaxoSmithKline plc
  • Bausch Health Companies Inc
  • Cipla Inc.
  • Orexo AB
  • Purdue Pharma L.P
  • Alvogen
  • Camurus AB
  • Hikma Pharmaceuticals PLC

TABLE OF CONTENTS

1.            Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        North America Addictions Therapeutics Market – By Treatment Type

1.3.2        North America Addictions Therapeutics Market – By Drug Type

1.3.3        North America Addictions Therapeutics Market – By Treatment Center

1.3.4        North America Addictions Therapeutics Market – By Distribution Channel

1.3.5        North America Addictions Therapeutics Market – By Country

2.            Addictions Therapeutics Market – Key Takeaways

3.            Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.            Addiction Therapeutics Market – Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

5.            Addiction Therapeutics Market – Key Market Dynamics

5.1       Market Drivers

5.1.1        Rising Addiction Among General Populace

5.1.2        Conduction of Awareness Campaigns

5.2       Market Restraint

5.2.1        Steeping Costs of Drug Development

5.3       Market Opportunity

5.3.1        Rising Demand for R&D from Contract Organizations

5.4       Future Trend

5.4.1        Consistent Launch of Therapeutics

5.5       Impact Analysis

6.            Addiction Therapeutics Market – North America Analysis

6.1       North America Addictions Therapeutics Marker Revenue Forecast and Analysis

7.            Addictions Therapeutics Market– Treatment Type

7.1       Overview

7.2       Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)

7.3       Nicotine Addiction Treatment

7.3.1        Overview

7.3.1.1      Nicotine Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

7.4       Alcohol Addiction Treatment

7.4.1        Overview

7.4.1.1      Alcohol Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

7.5       Opioid Addiction Treatment

7.5.1        Overview

7.5.1.1      Opioid Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

7.6       Other Substance Addiction Treatment

7.6.1        Overview

7.6.2        Other Substance Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.            Addictions Therapeutics Market– Drug Type

8.1       Overview

8.2       Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)

8.3       Varenicline

8.3.1        Overview

8.3.1.1      Varenicline: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.4       Bupropion

8.4.1        Overview

8.4.1.1      Bupropion: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.5       Nicotine Replacement Products

8.5.1        Overview

8.5.1.1      Nicotine Replacement Products: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.6       Buprenorphine

8.6.1        Overview

8.6.1.1      Buprenorphine: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.7       Naltrexone

8.7.1        Overview

8.7.1.1      Naltrexone: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.8       Disulfiram

8.8.1        Overview

8.8.1.1      Disulfiram: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

8.9       Others

8.9.1        Overview

8.9.1.1      Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

9.            Addictions Therapeutics Market– Treatment Center

9.1       Overview

9.2       Addictions Therapeutics Market Share, Treatment Center, 2019 and 2027 (%)

9.3       Outpatient Treatment Center

9.3.1        Overview

9.3.1.1      Outpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

9.4       Residential Treatment Center

9.4.1        Overview

9.4.1.1      Residential Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

9.5       Inpatient Treatment Center

9.5.1        Overview

9.5.1.1      Inpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

10.         Addictions Therapeutics Market– Distribution Channel

10.1    Overview

10.2    Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)

10.3    Hospital Pharmacies

10.3.1     Overview

10.3.1.1   Hospital Pharmacies: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

10.4    Medical Stores

10.4.1     Overview

10.4.1.1   Medical Stores: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

10.5    Others

10.5.1     Overview

10.5.1.1   Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

11.         Addiction Therapeutics Market Analysis and Forecasts To 2027 – North America Analysis

11.1    North America: Addiction Therapeutics Market

11.1.1     Overview

11.1.2     North America: Addiction Therapeutics Market, - Revenue and Forecast to 2027 (USD Million)

11.1.3     North America: Addiction Therapeutics Market, by Treatment Type– Revenue and Forecast to 2027 (USD Million)

11.1.4     North America: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

11.1.5     North America: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)

11.1.6     North America: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.7     North America: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)

11.1.8     US: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.1   US: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.8.2   US: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)

11.1.8.3   US: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

11.1.8.4   US: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)

11.1.8.5   US: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.9     Canada: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.1   Canada: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.9.2   Canada: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)

11.1.9.3   Canada: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

11.1.9.4   Canada: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)

11.1.9.5   Canada: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

11.1.10   Mexico: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.1 Mexico: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

11.1.10.2 Mexico: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)

11.1.10.3 Mexico: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

11.1.10.4 Mexico: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)

11.1.10.5 Mexico: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

12.         Impact of COVID-19 Pandemic on North America Addiction Therapeutics Market

12.1    North America: Impact Assessment of COVID-19 Pandemic

14.         Company Profiles

14.1    Indivior PLC

14.1.1     Key Facts

14.1.2     Business Description

14.1.3     Products and Services

14.1.4     Financial Overview

14.1.5     SWOT Analysis

14.1.6     Key Developments

14.2    Pfizer Inc.

14.2.1     Key Facts

14.2.2     Business Description

14.2.3     Products and Services

14.2.4     Financial Overview

14.2.5     SWOT Analysis

14.2.6     Key Developments

14.3    GlaxoSmithKline plc.

14.3.1     Key Facts

14.3.2     Business Description

14.3.3     Products and Services

14.3.4     Financial Overview

14.3.5     SWOT Analysis

14.3.6     Key Developments

14.4    Bausch Health Companies Inc.

14.4.1     Key Facts

14.4.2     Business Description

14.4.3     Products and Services

14.4.4     Financial Overview

14.4.5     SWOT Analysis

14.4.6     Key Developments

14.5    Cipla Inc.

14.5.1     Key Facts

14.5.2     Business Description

14.5.3     Products and Services

14.5.4     Financial Overview

14.5.5     SWOT Analysis

14.5.6     Key Developments

14.6    Orexo AB

14.6.1     Key Facts

14.6.2     Business Description

14.6.3     Products and Services

14.6.4     Financial Overview

14.6.5     SWOT Analysis

14.6.6     Key Developments

14.7    Purdue Pharma L.P.

14.7.1     Key Facts

14.7.2     Business Description

14.7.3     Products and Services

14.7.4     Financial Overview

14.7.5     SWOT Analysis

14.7.6     Key Developments

14.8    Alvogen

14.8.1     Key Facts

14.8.2     Business Description

14.8.3     Products and Services

14.8.4     Financial Overview

14.8.5     SWOT Analysis

14.8.6     Key Developments

14.9    Camurus AB

14.9.1     Key Facts

14.9.2     Business Description

14.9.3     Products and Services

14.9.4     Financial Overview

14.9.5     SWOT Analysis

14.9.6     Key Developments

14.10 Hikma Pharmaceuticals PLC

14.10.1   Key Facts

14.10.2   Business Description

14.10.3   Products and Services

14.10.4   Financial Overview

14.10.5   SWOT Analysis

14.10.6   Key Developments

15.         Appendix

15.1    About the Insight Partners

15.2    Glossary of Terms

 

LIST OF TABLES

Table 1.            North America: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)

Table 2.            North America: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 3.            North America: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)

Table 4.            North America: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 5.            US: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)

Table 6.            US: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 7.            US: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)

Table 8.            US: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 9.            Canada: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)

Table 10.          Canada: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 11.          Canada: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)

Table 12.          Canada: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 13.          Mexico: Addiction Therapeutics Market, by Treatment Type – Revenue and Forecast to 2027 (USD Million)

Table 14.          Mexico: Addiction Therapeutics Market, by Drug Type – Revenue and Forecast to 2027 (USD Million)

Table 15.          Mexico: Addiction Therapeutics Market, by Treatment Center – Revenue and Forecast to 2027 (USD Million)

Table 16.          Mexico: Addiction Therapeutics Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 17.       Glossary of Terms, Medical Adhesive and Sealants Market

LIST OF FIGURES

Figure 1.           Addictions Therapeutics Market Segmentation

Figure 2.           Addictions Therapeutics Market – By Geography

Figure 3.           Addictions Therapeutics Market Overview

Figure 4.           Nicotine Addiction Treatment Segment Held Largest Share of Addictions Therapeutics Market

Figure 5.           Addictions Therapeutics Market, by Geography (US$ Million)

Figure 6.           North America Addictions Therapeutics Market – Leading Country Markets (US$ Million)

Figure 7.           North America PEST Analysis

Figure 8.        Addiction Therapeutics Market Impact Analysis of Drivers and Restraint

Figure 9.        North America Addictions Therapeutics Market – Revenue Forecast and Analysis – 2019- 2027

Figure 10.        Addictions Therapeutics Market Share, Treatment Type, 2019 and 2027 (%)

Figure 11.        Nicotine Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 12.        Alcohol Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 13.        Opioid Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 14.        Other Substance Addiction Treatment: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 15.        Addictions Therapeutics Market Share, Drug Type, 2019 and 2027 (%)

Figure 16.        Varenicline: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 17.        Bupropion: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 18.        Nicotine Replacement Products: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 19.        Buprenorphine: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 20.        Naltrexone: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 21.        Disulfiram: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 22.        Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 23.        Addictions Therapeutics Market Share, Treatment Center, 2019 and 2027 (%)

Figure 24.        Outpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 25.        Residential Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 26.        Inpatient Treatment Center: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 27.        Addictions Therapeutics Market Share, Distribution Channel, 2019 and 2027 (%)

Figure 28.        Hospital Pharmacies: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 29.        Medical Stores: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 30.        Others: Addictions Therapeutics Market– Revenue and Forecast to 2027 (US$ million)

Figure 31.        North America: Addiction Therapeutics Market, by Key Country – Revenue (2019) (USD Million)

Figure 32.        North America: Addiction Therapeutics Market, Revenue and Forecast to 2027 (USD Million)

Figure 33.        North America: Addiction Therapeutics Market, by Country, 2019 & 2027 (%)

Figure 34.        US: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 35.        Canada: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 36.        Mexico: Addiction Therapeutics Market – Revenue and Forecast to 2027 (USD Million)

Figure 37.         Impact of COVID-19 Pandemic in North American Country Market

  • Indivior PLC
  • Pfizer Inc
  • GlaxoSmithKline plc
  • Bausch Health Companies Inc
  • Cipla Inc.
  • Orexo AB
  • Purdue Pharma L.P
  • Alvogen
  • Camurus AB
  • Hikma Pharmaceuticals PLC
  • Determine prospective investment areas based on a detailed trend analysis of the North America addictions therapeutics market over the next years.
  • Gain an in-depth understanding of the underlying factors driving demand for different addictions therapeutics segments in the top spending countries and identify the opportunities offered by each of them.
  • Strengthen your knowledge of the market in terms of demand drivers, industry trends, and the latest technological developments, among others.
  • Identify the major channels driving the North America addictions therapeutics market, providing a clear picture of future opportunities that will help Analyze, resulting in revenue expansion.
  • Channelize resources by focusing on the ongoing programs undertaken by the different countries within the North America addictions therapeutics market.

 

Report Code
Full Name
Country Name
Email Id
Phone Number
Job Title
Company
Requirement

Note : Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports
Report Name Published Date
North America Wind Turbine Condition Monitoring Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Component (Hardware, and Software a.. May 2022
North America Automotive System Simulation Software Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (Transmission, Engine, Ele.. May 2022
North America Cabinet LED Lighting Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type (In-cabinet Lighting and Under-Cabinet Ligh.. May 2022
Purchase Options
Single User License
$3000
$1800
Site License
$4000
$2400
Enterprise License
$5000
$3000
GET FREE SAMPLE PDF
Inquire before Buying Inquire for Discount
Subscription Member Price: FREE
Get Subscription